Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1997 Jun;105(Suppl 4):837–841. doi: 10.1289/ehp.97105s4837

Ethical, social, and legal issues surrounding studies of susceptible populations and individuals.

C L Soskolne 1
PMCID: PMC1470036  PMID: 9255569

Abstract

Calls for professional accountability have resulted in the development of ethics guidelines by numerous specialty and subspecialty groups of scientists. Indeed, guidelines among some health professions now address vulnerable and dependent groups: but these are silent on issues related to biomarkers. In parallel, attention has been drawn to human rights concerns associated with attempts to detect hypersusceptible workers, especially in democratic countries. Despite this, concern for vulnerable populations grows as advances in biomarker technology make the identification of genetic predisposition and susceptibility markers of both exposure and outcome more attainable. In this article, the principles derived from the ethical theory of utilitarianism provide the basis for principle-based ethical analysis. In addition, the four principles of biomedical ethics--respect for autonomy, beneficence, nonmaleficence, and social justice--are considered for biomarker studies. The need for a context in which ethical analysis is conducted and from which prevailing social values are shown to drive decisions of an ethical nature is emphasized; these include statutory regulation and law. Because biomarker studies can result in more harm than good, special precautions to inform research participants prior to any involvement in the use of biomarkers are needed. In addition, safeguards to maintain the privacy of data derived from biomarker studies must be developed and implemented prior to the application of these new technologies. Guidelines must be expanded to incorporate ethical, social, and legal considerations surrounding the introduction of new technologies for studying susceptible populations and individuals who may be vulnerable to environmental exposures.

Full text

PDF
837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashford N. A. Monitoring the worker and the community for chemical exposure and disease: legal and ethical considerations in the US. Clin Chem. 1994 Jul;40(7 Pt 2):1426–1437. [PubMed] [Google Scholar]
  2. Ashford N. A. Policy considerations for human monitoring in the workplace. J Occup Med. 1986 Aug;28(8):563–568. doi: 10.1097/00043764-198608000-00007. [DOI] [PubMed] [Google Scholar]
  3. Atherley G. Human rights versus occupational medicine. Int J Health Serv. 1983;13(2):265–275. doi: 10.2190/KGM7-HBFF-L5KE-GF3W. [DOI] [PubMed] [Google Scholar]
  4. Atherley G., Johnston N., Tennassee M. Biomedical surveillance: rights conflict with rights. J Occup Med. 1986 Oct;28(10):958–965. doi: 10.1097/00043764-198610000-00013. [DOI] [PubMed] [Google Scholar]
  5. Correa P. Molecular and biochemical methods in cancer epidemiology and prevention: the path between the laboratory and the population. AACR special conference in cancer research. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):85–88. [PubMed] [Google Scholar]
  6. Friend S. H. Genetic models for studying cancer susceptibility. Science. 1993 Feb 5;259(5096):774–775. doi: 10.1126/science.8430329. [DOI] [PubMed] [Google Scholar]
  7. Grandjean P., Sorsa M. Ethical aspects of genetic predisposition to environmentally-related disease. Sci Total Environ. 1996 May 17;184(1-2):37–43. doi: 10.1016/0048-9697(95)04986-x. [DOI] [PubMed] [Google Scholar]
  8. Green J. Detecting the hypersusceptible worker: genetics and politics in industrial medicine. Int J Health Serv. 1983;13(2):247–264. doi: 10.2190/7EQD-K9NG-42P1-KD51. [DOI] [PubMed] [Google Scholar]
  9. Higginson J., Chu F. Ethical considerations and responsibilities in communicating health risk information. J Clin Epidemiol. 1991;44 (Suppl 1):51S–56S. doi: 10.1016/0895-4356(91)90175-9. [DOI] [PubMed] [Google Scholar]
  10. Hulka B. S. ASPO Distinguished Achievement Award Lecture. Epidemiological studies using biological markers: issues for epidemiologists. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):13–19. [PubMed] [Google Scholar]
  11. Jonsen A. R. Ethical considerations and responsibilities when communicating health risk information. J Clin Epidemiol. 1991;44 (Suppl 1):69S–72S. doi: 10.1016/0895-4356(91)90178-c. [DOI] [PubMed] [Google Scholar]
  12. Knoppers B. M., Chadwick R. The Human Genome Project: under an international ethical microscope. Science. 1994 Sep 30;265(5181):2035–2036. doi: 10.1126/science.8091225. [DOI] [PubMed] [Google Scholar]
  13. Lappé M. Ethical issues in testing for differential sensitivity to occupational hazards. J Occup Med. 1983 Nov;25(11):797–808. [PubMed] [Google Scholar]
  14. Loomis D., Wing S. Is molecular epidemiology a germ theory for the end of the twentieth century? Int J Epidemiol. 1990 Mar;19(1):1–3. doi: 10.1093/ije/19.1.1. [DOI] [PubMed] [Google Scholar]
  15. McMichael A. J. Invited commentary--"molecular epidemiology": new pathway or new travelling companion? Am J Epidemiol. 1994 Jul 1;140(1):1–11. doi: 10.1093/oxfordjournals.aje.a117153. [DOI] [PubMed] [Google Scholar]
  16. Omenn G. S. Predictive identification of hypersusceptible individuals. J Occup Med. 1982 May;24(5):369–374. doi: 10.1097/00043764-198205000-00007. [DOI] [PubMed] [Google Scholar]
  17. Pearce N., de Sanjose S., Boffetta P., Kogevinas M., Saracci R., Savitz D. Limitations of biomarkers of exposure in cancer epidemiology. Epidemiology. 1995 Mar;6(2):190–194. doi: 10.1097/00001648-199503000-00020. [DOI] [PubMed] [Google Scholar]
  18. Perera F. P., Hemminki K., Gryzbowska E., Motykiewicz G., Michalska J., Santella R. M., Young T. L., Dickey C., Brandt-Rauf P., De Vivo I. Molecular and genetic damage in humans from environmental pollution in Poland. Nature. 1992 Nov 19;360(6401):256–258. doi: 10.1038/360256a0. [DOI] [PubMed] [Google Scholar]
  19. Perera F. P. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst. 1987 May;78(5):887–898. [PubMed] [Google Scholar]
  20. Perera F. P., Weinstein I. B. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis. 1982;35(7):581–600. doi: 10.1016/0021-9681(82)90078-9. [DOI] [PubMed] [Google Scholar]
  21. Rothman N., Stewart W. F., Caporaso N. E., Hayes R. B. Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):299–303. [PubMed] [Google Scholar]
  22. Samuels S. W. Medical surveillance: biological, social, and ethical parameters. J Occup Med. 1986 Aug;28(8):572–577. doi: 10.1097/00043764-198608000-00009. [DOI] [PubMed] [Google Scholar]
  23. Sandman P. M. Emerging communication responsibilities of epidemiologists. J Clin Epidemiol. 1991;44 (Suppl 1):41S–50S. doi: 10.1016/0895-4356(91)90174-8. [DOI] [PubMed] [Google Scholar]
  24. Schulte P. A. Contribution of biological markers to occupational health. Am J Ind Med. 1991;20(4):435–446. doi: 10.1002/ajim.4700200402. [DOI] [PubMed] [Google Scholar]
  25. Schulte P. A. Ethical issues in the communication of results. J Clin Epidemiol. 1991;44 (Suppl 1):57S–61S. doi: 10.1016/0895-4356(91)90176-a. [DOI] [PubMed] [Google Scholar]
  26. Schulte P. A. Methodologic issues in the use of biologic markers in epidemiologic research. Am J Epidemiol. 1987 Dec;126(6):1006–1016. doi: 10.1093/oxfordjournals.aje.a114740. [DOI] [PubMed] [Google Scholar]
  27. Schulte P. A., Ringen K., Altekruse E. B., Gullen W. H., Davidson K., Anderson S. S., Patton M. G. Notification of a cohort of workers at risk of bladder cancer. J Occup Med. 1985 Jan;27(1):19–28. [PubMed] [Google Scholar]
  28. Schulte P. A., Ringen K. Notification of workers at high risk: an emerging public health problem. Am J Public Health. 1984 May;74(5):485–491. doi: 10.2105/ajph.74.5.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shields P. G., Harris C. C. Molecular epidemiology and the genetics of environmental cancer. JAMA. 1991 Aug 7;266(5):681–687. [PubMed] [Google Scholar]
  30. Smith P. J. Molecular genetics and human cancer. Med J Aust. 1993 Jun 21;158(12):851–853. doi: 10.5694/j.1326-5377.1993.tb137677.x. [DOI] [PubMed] [Google Scholar]
  31. Spivey G. H. Health risk communication--a view from within industry. J Clin Epidemiol. 1991;44 (Suppl 1):63S–67S. doi: 10.1016/0895-4356(91)90177-b. [DOI] [PubMed] [Google Scholar]
  32. Vainio H., Husgafvel-Pursiainen K. Elimination of environmental factors or elimination of individuals: biomarkers and prevention. J Occup Environ Med. 1995 Jan;37(1):12–13. doi: 10.1097/00043764-199501000-00002. [DOI] [PubMed] [Google Scholar]
  33. Van Damme K., Casteleyn L., Heseltine E., Huici A., Sorsa M., van Larebeke N., Vineis P. Individual susceptibility and prevention of occupational diseases: scientific and ethical issues. J Occup Environ Med. 1995 Jan;37(1):91–99. doi: 10.1097/00043764-199501000-00013. [DOI] [PubMed] [Google Scholar]
  34. Vineis P., Schulte P. A. Scientific and ethical aspects of genetic screening of workers for cancer risk: the case of the N-acetyltransferase phenotype. J Clin Epidemiol. 1995 Feb;48(2):189–197. doi: 10.1016/0895-4356(94)00131-9. [DOI] [PubMed] [Google Scholar]
  35. Vineis P., Soskolne C. L. Cancer risk assessment and management. An ethical perspective. J Occup Med. 1993 Sep;35(9):902–908. doi: 10.1097/00043764-199309000-00013. [DOI] [PubMed] [Google Scholar]
  36. Vineis P. Use of biomarkers in epidemiology. The example of metabolic susceptibility to cancer. Toxicol Lett. 1995 May;77(1-3):163–168. doi: 10.1016/0378-4274(95)03286-x. [DOI] [PubMed] [Google Scholar]
  37. Vineis P. Uses of biochemical and biological markers in occupational epidemiology. Rev Epidemiol Sante Publique. 1992;40 (Suppl 1):S63–S69. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES